Search
Eterna Therapeutics Inc
ERNAAdd to Watchlist
3.280USD
-0.190-5.48%
Close 07-31 16:00（ET）Quotes delayed by 15 min
152.98KMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-30The current earnings forecast score of Eterna Therapeutics Inc is 8.00, ranking 171 out of 384 in the Biotechnology & Medical Research industry.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
30.000
Target Price
+779.77%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Eterna Therapeutics Inc
ERNA
1
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is the analyst rating for Eterna Therapeutics Inc?
Based on the ratings of Eterna Therapeutics Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.